Health Care & Life Sciences » Pharmaceuticals | vTv Therapeutics Inc.

vTv Therapeutics Inc. Cl A | Income Statement

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
1,549.00
519.00
634.00
291.00
12,434
SG&A Expense
29,582.00
38,160.00
55,389.00
50,776.00
32,040
EBIT
28,897.00
38,142.00
55,020.00
50,682.00
19,824
Unusual Expense
-
695.00
-
-
638
Non Operating Income/Expense
1,195.00
535.00
22.00
190.00
46
Interest Expense
6,009.00
1,735.00
398.00
3,092.00
3,290
Pretax Income
36,101.00
41,107.00
55,353.00
53,847.00
23,645
Income Tax
-
-
-
800.00
200
Consolidated Net Income
235,461.00
41,107.00
55,353.00
54,647.00
24,584
Net Income
235,461.00
27,498.00
16,352.00
16,144.00
8,650
Net Income After Extraordinaries
235,461.00
27,498.00
16,352.00
16,144.00
8,650
Net Income Available to Common
235,461.00
27,498.00
16,352.00
16,144.00
8,650
EPS (Basic)
6.93
3.32
1.71
1.67
0.69
Basic Shares Outstanding
33,984.40
8,276.50
9,545.50
9,693.30
12,449.20
EPS (Diluted)
6.93
3.32
1.71
1.67
0.69
Diluted Shares Outstanding
33,984.40
8,276.50
9,545.50
9,693.30
12,449.20
EBITDA
28,033.00
37,641.00
54,755.00
50,485.00
19,606
Non-Operating Interest Income
-
-
87.00
117.00
61
Minority Interest Expense
-
13,609.00
39,001.00
38,503.00
15,934
Other After Tax Income (Expense)
199,360.00
-
-
-
739

About vTv Therapeutics

View Profile
Address
4170 Mendenhall Oaks Parkway
High Point North Carolina 27265
United States
Employees -
Website http://www.vtvtherapeutics.com
Updated 07/08/2019
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company. The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.